Roseburia inulinivorans for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Roseburia inulinivorans for Health & Longevity

Created on 07/17/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A fibre-eating gut bacterium that makes a beneficial fat which fuels the gut lining. Its presence is linked to greater muscle strength, and it grows scarcer with age. The strongest evidence comes from animals; human data show links, not proof, and no product exists. For now, a fibre-rich diet is the realistic way to support it. (Full Review)

Protocol

Strategy
Prebiotic fibre
Inulin, fructo-oligosaccharides, resistant starch from whole foods (chicory, onions, garlic, cooked-and-cooled starches)
Dose
~5–15 g/day added fibre
Start low (3–5 g), titrate up every 1–2 weeks as tolerated, with plenty of water
Intake
Split, with meals
Two or more smaller servings per day improve tolerance and steady the substrate supply
Time to effect
Strength & metabolic effects
Months
Any downstream health change expected only over months; unproven in humans for this species
Microbiome shift
Days–weeks
A fibre strategy begins shifting the microbiome within days to a few weeks

Benefits

Contraindications
  • Severe immunosuppression (live products)
  • Critical illness or central venous line (live products)
  • Short bowel syndrome or severely damaged gut barrier
  • Recently advised against live cultures by a clinician
    •
Key Interactions
  • Antibiotics (e.g. amoxicillin, ciprofloxacin, metronidazole)
  • Immunosuppressants & chemotherapy (e.g. corticosteroids, tacrolimus)
  • Over-the-counter laxatives, anti-diarrhoeals, anti-inflammatories (e.g. ibuprofen)
  • Additive prebiotic fibres (inulin, fructo-oligosaccharides, resistant starch)
  • Other probiotics or live strains
  • Pregnancy or breastfeeding (experimental live products)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Digestive adjustment effects
    •
  • Speculative: Infection or translocation in vulnerable people; amino-acid depletion effects; overproduction of propanol and propionate
    •

Monitoring

Marker Target Why
Stool Roseburia / butyrate-producer abundance Present and stable-to-rising relative abundance Confirms the target population is present and responding
Stool short-chain fatty acids (incl. butyrate) Butyrate in the mid-to-upper reference range Reflects functional output of butyrate producers
hs-CRP Below 1.0 mg/L Tracks low-grade inflammation the gut barrier influences
HbA1c Below 5.4% Screens for the metabolic health the species is associated with
Fasting glucose 75–86 mg/dL Complements HbA1c for glucose regulation
Handgrip strength At or above age- and sex-referenced norms Functional readout of the species' headline proposed benefit

Cadence: Baseline before starting; reassess ~3 months after a consistent change, then every 6–12 months

Qualitative Assessment

  • Energy and daily vitality
  • Digestive comfort and regularity
  • Physical strength and ease with everyday tasks such as carrying and climbing stairs
  • General sense of recovery and resilience
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.